BARCLAY A PHILLIPS Insider Trading $NVAX NOVAVAX INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BARCLAY A PHILLIPS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BARCLAY A PHILLIPS. BARCLAY A PHILLIPS is SVP, Chief Financial Officer in NOVAVAX INC ($NVAX) and Director in MICROMET, INC. ($MITI) and Director in IMMUNIC, INC. ($VTL) and SVP & Chief Financial Officer in G1 Therapeutics, Inc. ($GTHX).
BARCLAY A PHILLIPS in NOVAVAX INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BARCLAY A PHILLIPS: SVP, Chief Financial Officer
Holdings: 38,669 shares
Current Value: $50,656
Latest Transaction: Aug 01 2017
$NVAX Market Capitalization: $355.26M
$NVAX Previous Close: $1.31
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BARCLAY A PHILLIPS in NOVAVAX INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GTHX, VTL, MITI, NVAX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 01 2017 | NVAX | NOVAVAX INC | PHILLIPS BARCLAY A | SVP, Chief Financia ... | Buy | P | 0.89 | 2,057 | 1,831 | 38,669 | 36.6 K to 38.7 K (+5.62 %) |
| May 11 2017 | NVAX | NOVAVAX INC | PHILLIPS BARCLAY A | SVP, Chief Financia ... | Buy | P | 0.84 | 25,000 | 20,950 | 36,612 | 11.6 K to 36.6 K (+215.29 %) |
| Feb 02 2017 | NVAX | NOVAVAX INC | PHILLIPS BARCLAY A | SVP, Chief Financia ... | Buy | P | 1.12 | 1,633 | 1,829 | 11,612 | 10 K to 11.6 K (+16.36 %) |
| Nov 16 2016 | NVAX | NOVAVAX INC | PHILLIPS BARCLAY A | SVP, Chief Financia ... | Option Exercise | A | 1.35 | 125,000 | 168,750 | 125,000 | |
| Nov 16 2016 | NVAX | NOVAVAX INC | PHILLIPS BARCLAY A | SVP, Chief Financia ... | Option Exercise | A | 1.35 | 125,000 | 168,750 | 125,000 | |
| Aug 02 2016 | NVAX | NOVAVAX INC | PHILLIPS BARCLAY A | SVP, Chief Financia ... | Buy | P | 4.29 | 422 | 1,810 | 9,979 | 9.6 K to 10 K (+4.42 %) |
| Mar 17 2016 | NVAX | NOVAVAX INC | PHILLIPS BARCLAY A | SVP, Chief Financia ... | Option Exercise | A | 4.99 | 225,000 | 1,122,750 | 225,000 | |
| Feb 01 2016 | NVAX | NOVAVAX INC | PHILLIPS BARCLAY A | SVP, Chief Financia ... | Buy | P | 4.38 | 405 | 1,774 | 9,557 | 9.2 K to 9.6 K (+4.43 %) |
| Aug 21 2015 | NVAX | NOVAVAX INC | PHILLIPS BARCLAY A | SVP, Chief Financia ... | Sell | S | 12.81 | 10,000 | 128,122 | 9,152 | 19.2 K to 9.2 K (-52.21 %) |
| Aug 21 2015 | NVAX | NOVAVAX INC | PHILLIPS BARCLAY A | SVP, Chief Financia ... | Sell | S | 13.20 | 18,656 | 246,201 | 19,152 | 37.8 K to 19.2 K (-49.34 %) |
| Aug 04 2015 | NVAX | NOVAVAX INC | PHILLIPS BARCLAY A | SVP, Chief Financia ... | Buy | P | 2.28 | 764 | 1,742 | 37,808 | 37 K to 37.8 K (+2.06 %) |
| Mar 09 2015 | NVAX | NOVAVAX INC | PHILLIPS BARCLAY A | SVP, Chief Financia ... | Option Exercise | A | 8.94 | 200,000 | 1,788,000 | 200,000 |
Page: 1